Jon A. Weidanz Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology Texas Tech University Health Sciences Center Biography Publications Institution JoVE Articles Jon A. Weidanz has not added a biography. If you are Jon A. Weidanz and would like to personalize this page please email our Author Liaison for assistance. Publications A Novel T-cell Receptor Mimic Defines Dendritic Cells That Present an Immunodominant West Nile Virus Epitope in Mice European Journal of Immunology. Jul, 2014 | Pubmed ID: 24723377 Antitumor Activity of a Monoclonal Antibody Targeting Major Histocompatibility Complex Class I-Her2 Peptide Complexes Journal of the National Cancer Institute. Feb, 2013 | Pubmed ID: 23300219 TCR-like Biomolecules Target Peptide/MHC Class I Complexes on the Surface of Infected and Cancerous Cells International Reviews of Immunology. Oct-Dec, 2011 | Pubmed ID: 22053972 Expanding the Targets Available to Therapeutic Antibodies Via Novel Disease-specific Markers International Reviews of Immunology. Oct-Dec, 2011 | Pubmed ID: 22053971 TCR Mimic Monoclonal Antibodies Induce Apoptosis of Tumor Cells Via Immune Effector-independent Mechanisms Journal of Immunology (Baltimore, Md. : 1950). Mar, 2011 | Pubmed ID: 21282517 A Novel Vascular Targeting Strategy for Brain-derived Endothelial Cells Using a TCR Mimic Antibody Journal of Cellular Physiology. Nov, 2010 | Pubmed ID: 20506235 Single-chain HLA-A2 MHC Trimers That Incorporate an Immundominant Peptide Elicit Protective T Cell Immunity Against Lethal West Nile Virus Infection Journal of Immunology (Baltimore, Md. : 1950). Apr, 2010 | Pubmed ID: 20212098 TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth in Vivo Using Breast Cancer Models Journal of Immunology (Baltimore, Md. : 1950). Feb, 2010 | Pubmed ID: 20065111 Direct Discovery and Validation of a Peptide/MHC Epitope Expressed in Primary Human Breast Cancer Cells Using a TCRm Monoclonal Antibody with Profound Antitumor Properties Cancer Immunology, Immunotherapy : CII. Apr, 2010 | Pubmed ID: 19779714 Aspirin Inhibits Camptothecin-induced P21CIP1 Levels and Potentiates Apoptosis in Human Breast Cancer Cells International Journal of Oncology. Mar, 2009 | Pubmed ID: 19212664 RAAV/Her-2/neu Loading of Dendritic Cells for a Potent Cellular-mediated MHC Class I Restricted Immune Response Against Ovarian Cancer Viral Immunology. Dec, 2008 | Pubmed ID: 19115932 Sperm Protein 17 is a Suitable Target for Adoptive T-cell-based Immunotherapy in Human Ovarian Cancer Journal of Immunotherapy (Hagerstown, Md. : 1997). Oct, 2008 | Pubmed ID: 18779750 Assessing Vaccine Potency Using TCRmimic Antibodies Vaccine. Jun, 2008 | Pubmed ID: 18353510 Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201 Journal of Proteome Research. Apr, 2008 | Pubmed ID: 18345606 A NOD/SCID Tumor Model for Human Ovarian Cancer That Allows Tracking of Tumor Progression Through the Biomarker Sp17 Journal of Immunological Methods. Apr, 2007 | Pubmed ID: 17336323 Development and Implementation of a Direct Detection, Quantitation and Validation System for Class I MHC Self-peptide Epitopes Journal of Immunological Methods. Jan, 2007 | Pubmed ID: 17134715 Levels of Specific Peptide-HLA Class I Complex Predicts Tumor Cell Susceptibility to CTL Killing Journal of Immunology (Baltimore, Md. : 1950). Oct, 2006 | Pubmed ID: 17015692 Antibody Targeting to a Class I MHC-peptide Epitope Promotes Tumor Cell Death Journal of Immunology (Baltimore, Md. : 1950). Sep, 2006 | Pubmed ID: 16951384 Attenuation of Acute Rejection in a Rat Liver Transplantation Model by a Liver-targeted Dextran Prodrug of Methylprednisolone Transplantation. Mar, 2006 | Pubmed ID: 16534468 ATR Blockade Reduces IFN-gamma Production in Lymphocytes in Vivo and in Vitro Kidney International. Jun, 2005 | Pubmed ID: 15882256 Testing Recombinant Adeno-associated Virus-gene Loading of Dendritic Cells for Generating Potent Cytotoxic T Lymphocytes Against a Prototype Self-antigen, Multiple Myeloma HM1.24 Blood. Nov, 2003 | Pubmed ID: 12855576 Upptäckt av HLA-antigen Biomarkers i bröstcancer Använda Label fria Biosensor Teknik Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
Upptäckt av HLA-antigen Biomarkers i bröstcancer Använda Label fria Biosensor Teknik Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
